Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125212654 | 12521265 | 4 | F | 20160523 | 20160729 | 20160701 | 20160811 | EXP | US-CELGENEUS-USA-2016066273 | CELGENE | 82.28 | YR | M | Y | 68.95000 | KG | 20160811 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125212654 | 12521265 | 1 | PS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | A2135B | 21880 | 10 | MG | CAPSULES | QD | |||||
| 125212654 | 12521265 | 2 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | A2135B | 21880 | 15 | MG | CAPSULES | ||||||
| 125212654 | 12521265 | 3 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | U | U | 0 | UNKNOWN | ||||||||
| 125212654 | 12521265 | 4 | SS | COUMADIN | WARFARIN SODIUM | 1 | Unknown | U | U | 0 | UNKNOWN | ||||||||
| 125212654 | 12521265 | 5 | SS | CARVEDILOL. | CARVEDILOL | 1 | Unknown | U | U | 0 | UNKNOWN | ||||||||
| 125212654 | 12521265 | 6 | SS | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Unknown | U | U | 0 | UNKNOWN | ||||||||
| 125212654 | 12521265 | 7 | SS | TORSEMIDE. | TORSEMIDE | 1 | Unknown | U | U | 0 | UNKNOWN | ||||||||
| 125212654 | 12521265 | 8 | C | COLCHICINE. | COLCHICINE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125212654 | 12521265 | 9 | C | INDOMETHACIN. | INDOMETHACIN | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125212654 | 12521265 | 1 | Plasma cell myeloma |
| 125212654 | 12521265 | 3 | Product used for unknown indication |
| 125212654 | 12521265 | 4 | Product used for unknown indication |
| 125212654 | 12521265 | 5 | Product used for unknown indication |
| 125212654 | 12521265 | 6 | Product used for unknown indication |
| 125212654 | 12521265 | 7 | Product used for unknown indication |
| 125212654 | 12521265 | 8 | Product used for unknown indication |
| 125212654 | 12521265 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125212654 | 12521265 | HO |
| 125212654 | 12521265 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125212654 | 12521265 | Cardiac failure congestive | |
| 125212654 | 12521265 | Dizziness | |
| 125212654 | 12521265 | Fall | |
| 125212654 | 12521265 | Haemorrhage | |
| 125212654 | 12521265 | Increased tendency to bruise | |
| 125212654 | 12521265 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125212654 | 12521265 | 1 | 201511 | 0 | ||
| 125212654 | 12521265 | 2 | 20160228 | 0 |